Jennifer A DeSimone
Recent advances in primary cutaneous T-cell lymphoma
DeSimone J, Sodha P, Desislava I, Dummer R, Cozzio A, Guenova E. Recent advances in primary cutaneous T-cell lymphoma. Curr Opin Oncol 2015; 27:128-33.
Mar 1, 2015Recent advances in primary cutaneous T-cell lymphoma
Mar 1, 2015Curr Opin Oncol 2015; 27:128-33
DeSimone Jennifer A, Sodha Pooja, Desislava Ignatova, Dummer Reinhard, Cozzio Antonio, Guenova Emmanuella
TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma
Guenova E, Kupper T, Fisher D, Tawa M, Rook A, Schaekel K, Schlapbach C, Dowlatshahi M, Jiang Y, DeSimone J, Teague J, Watanabe R, Clark R. TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma. Clin Cancer Res 2013; 19:3755-63.
Jun 19, 2013TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma
Jun 19, 2013Clin Cancer Res 2013; 19:3755-63
Guenova Emmanuella, Kupper Thomas S, Fisher David C, Tawa Marianne, Rook Alain H, Schaekel Knut, Schlapbach Christoph, Dowlatshahi Mitra, Jiang Ying, DeSimone Jennifer A, Teague Jessica E, Watanabe Rei, Clark Rachael A
Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma
DeSimone J, Kupper T, Hansen J, Dorosario A, Noell C, Aldridge J, Chaney K, Carter J, Guenova E, Devlin P. Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma. J Am Acad Dermatol 2013; 69:61-5.
Feb 26, 2013Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma
Feb 26, 2013J Am Acad Dermatol 2013; 69:61-5
DeSimone Jennifer A, Kupper Thomas S, Hansen Jorgen L, Dorosario Andrew A, Noell Claire M, Aldridge Julie R, Chaney Keri S, Carter Joi B, Guenova Emmanuella, Devlin Phillip M